These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3830417)

  • 21. Synthesis and antihypertensive activity of substituted (2,6-dichlorobenzylideneamino) guanidines and some hydrazone derivatives of C-cyanoformamidrazone.
    Emilsson H; Selander H
    Acta Pharm Suec; 1988; 25(2):75-86. PubMed ID: 3218546
    [No Abstract]   [Full Text] [Related]  

  • 22. Mechanisms of converting enzyme inhibition: studies in experimental animals.
    Dinicolantonio R; Mendelsohn FA; Takata Y; Hutchinson JS; Doyle AE
    Neth J Med; 1984; 27(4):153-60. PubMed ID: 6330589
    [No Abstract]   [Full Text] [Related]  

  • 23. Cyclic guanidines. XV. Synthesis and biological activities of (substituted phenyl)-imidazo[1,2-a]imidazole derivatives.
    Ishikawa F; Kitagawa M; Satoh Y; Saegusa J; Tanaka S; Shibamura S; Chiba T
    Chem Pharm Bull (Tokyo); 1985 Jul; 33(7):2838-48. PubMed ID: 4085043
    [No Abstract]   [Full Text] [Related]  

  • 24. Reproductive toxicity studies of rentiapril.
    Cozens DD; Barton SJ; Clark R; Hughes EW; Offer JM; Yamamoto Y
    Arzneimittelforschung; 1987 Feb; 37(2):164-9. PubMed ID: 3034299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and biological evaluation of N-mercaptoacylproline and N-mercaptoacylthiazolidine-4-carboxylic acid derivatives as leukotriene A4 hydrolase inhibitors.
    Enomoto H; Morikawa Y; Miyake Y; Tsuji F; Mizuchi M; Suhara H; Fujimura K; Horiuchi M; Ban M
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4529-32. PubMed ID: 18674901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antihypertensive activity of arylidenaminoguanidine derivatives.
    Mamolo MG; Vio L; Fabris B; Fischetti F; Carretta R; Giraldi T
    Farmaco Sci; 1986 Nov; 41(11):873-80. PubMed ID: 3803565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Guanidinoalkyl-azacycloalkanes: chemical structure and antihypertensive action].
    Wollweber H; Wilms H; Hiltmann R; Stoepel K; Kroneberg G
    Arzneimittelforschung; 1971 Dec; 21(12):2089-100. PubMed ID: 4400569
    [No Abstract]   [Full Text] [Related]  

  • 28. Inhibitor of angiotensin I converting enzyme: (4R)-3-[(2S)-3-mercapto-2-methylpropanoyl]-4-thiazolidinecarboxylic acid (YS-980).
    Funae Y; Komori T; Sasaki D; Yamamoto K
    Biochem Pharmacol; 1980 Jun; 29(11):1543-7. PubMed ID: 6249321
    [No Abstract]   [Full Text] [Related]  

  • 29. Synthesis of pyrido[1,2-a]pyrimidin-4-ones. Potential antihypertensive agents. III.
    Da Settimo A; Ferrarini PL; Mori C; Primofiore G; Subissi A
    Farmaco Sci; 1986 Dec; 41(12):926-33. PubMed ID: 3556566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Biochemical basis for the effects of radioprotective substances].
    Romantsev EF; Blokhina VD; Zhulanova ZI; Koshcheenko NN; Filippovich IV
    Radiobiologiia; 1977; 17(5):672-86. PubMed ID: 339265
    [No Abstract]   [Full Text] [Related]  

  • 31. Synthesis and antihypertensive activity of some 3-substituted 4H-1,2,4-triazoles.
    Emilsson H; Selander H; Gaarder J
    Acta Pharm Suec; 1987; 24(3):123-34. PubMed ID: 3687469
    [No Abstract]   [Full Text] [Related]  

  • 32. Aminoethers of (+)-1,3,3-trimethyl-2-oxabicyclo[2.2.2]-octan-6-hydroxyimine with hypotensive activity. II.
    Bondavalli F; Bruno O; Ranise A; Schenone P; Filippelli A; Marrazzo R; Di Guglielmo R; Marmo E
    Farmaco Sci; 1986 Aug; 41(8):630-6. PubMed ID: 2874996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antihypertensive mechanism of an angiotensin converting enzyme inhibitor, SA446, in dogs.
    Nishimura K; Okunishi H; Miyazaki M
    Bull Osaka Med Coll; 1989 Nov; 35(1-2):29-37. PubMed ID: 2486241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thiol compounds. I. Synthesis and antihypertensive activity of mercaptoacylamino acids.
    Oya M; Matsumoto J; Takashina H; Iwao J; Funae Y
    Chem Pharm Bull (Tokyo); 1981 Jan; 29(1):63-70. PubMed ID: 7261198
    [No Abstract]   [Full Text] [Related]  

  • 35. Synthesis and antihypertensive activities of 1,4-dihydropyridine-5-phosphonate derivatives. II.
    Morita I; Kunimoto K; Tsuda M; Tada S; Kise M; Kimura K
    Chem Pharm Bull (Tokyo); 1987 Oct; 35(10):4144-54. PubMed ID: 3435941
    [No Abstract]   [Full Text] [Related]  

  • 36. [Synthesis and antihypertensive activity of quinazolinone derivatives].
    Liu KC; Hsu LY
    Arch Pharm (Weinheim); 1985 Jun; 318(6):502-5. PubMed ID: 4026544
    [No Abstract]   [Full Text] [Related]  

  • 37. Fusaric acid derivatives and analogues as possible antihypertensive agents. Note III.
    Colautti A; Rubessa F; Vio L
    Farmaco Sci; 1981 Apr; 36(4):274-82. PubMed ID: 7250361
    [No Abstract]   [Full Text] [Related]  

  • 38. [Derivatives of 3-hydrazinopyridazine. II. Synthesis and antihypertensive activity of new 3-hydrazino-6-monoalkylaminopyridazines].
    Parravicini F; Scarpitta G; Dorigotti L; Pifferi G
    Farmaco Sci; 1978 Feb; 33(2):99-105. PubMed ID: 631323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potentiating mechanism of bradykinin action on smooth muscle by sulfhydryl compounds.
    Iso T; Nishimura K; Oya M; Iwao J
    Eur J Pharmacol; 1979 Mar; 54(3):303-5. PubMed ID: 428428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and antihypertensive activity of some derivatives of diaminoguanidine and 3-hydrazino-4H-1,2,4-triazoles.
    Emilsson H; Lewisson A; Selander H
    Acta Pharm Suec; 1983; 20(3):161-80. PubMed ID: 6637515
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.